• Thematic Report
    Aug. 30, 2024

    The life sciences industry is transforming significantly, driven by rapid technology advances and evolving customer expectations. In this dynamic landscape, commercial technology specialists are emerging as key players, offering innovative solutions across omnichannel engagement, intelligence, and…
  • Tech Launch Perspective
    Aug. 07, 2024

    Following the Veeva-Salesforce split, the life sciences industry is undergoing significant changes in the base Customer Relationship Management (CRM) platform and associated technology tools and platforms. Additionally, enterprises seek a unified approach to engage customers across…
  • Thematic Report
    Aug. 05, 2024

    Following the pandemic, industries began investing in personalized Customer Experience (CX) worldwide, including the life sciences commercial sector. To stay resilient and keep pace with the evolving landscape, the life sciences industry is adopting technology to…
  • Thematic Report
    June 20, 2024

    Patient recruitment is a complex and dynamic part of clinical trial management, requiring proactive strategies, collaborations, and innovation to overcome challenges and achieve enrollment targets. Patient recruitment is vital for clinical trials, yet it presents challenges…
  • Blog
    June 03, 2024

    What impact will Salesforce’s upcoming global partnership with IQVIA have? Get the expert view here, orget in touch to understand how this significant move in the life sciences CRM sector might impact your business.Once again, the…
  • PEAK Matrix®
    June 03, 2024

    The evolving regulatory landscape poses significant challenges for life sciences enterprises. Enterprises struggle to navigate complex compliance frameworks, stay updated with emerging regulations, and manage diverse geographical requirements, all vital for achieving regulatory compliance and securing…
  • Viewpoint
    May 31, 2024

    Healthcare organizations use Revenue Cycle Management (RCM) to manage the administrative and clinical functions related to processing claims, receiving payments, and generating revenue. The cycle begins with a patient scheduling an appointment and continues until the…
  • Blog
    April 26, 2024

    Life sciences enterprises are undergoing a generational shift, transitioning from outdated legacy customer relationship management (CRM) systems to modern Customer Experience Platforms (CXP). Discover the three emerging customer engagement layers in these platforms, the readiness of…
  • LinkedIn Live
    April 25, 2024

    Life sciences enterprises are facing a pivotal juncture that demands a strategic decision regarding their CRM ecosystems after the Veeva-Salesforce split. Watch this interactive LinkedIn Live discussion as our expert analysts explore the critical shift from…
  • Viewpoint
    April 16, 2024

    The life science industry’s focus on driving improved customer experiences has steadily grown. Investments to improve customer experiences rank among the top priorities of life sciences enterprises. These enterprises must align customer engagement strategies with the…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Provider Compendium
    Feb. 08, 2024

    Over the past year, enterprises have faced significant macroeconomic and geopolitical challenges. The potential uncertainties surrounding the implementation of the Inflation Reduction Act (IRA), the escalation in federal interest rates aimed at curbing inflation, and the…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Provider Compendium
    Dec. 21, 2023

    In response to the global shift in investment priorities toward personalized Customer Experience (CX) post-pandemic, the life sciences commercial technology space is also redirecting its focus. Adapting to the changing landscape, the industry is increasingly leveraging…
  • Market Insights™
    Dec. 04, 2023

  • Market Insights™
    Dec. 04, 2023

  • PEAK Matrix®
    Oct. 30, 2023

    Since the pandemic, industries worldwide have shifted their investment priorities to focusing on delivering personalized Customer Experience (CX), and the life sciences commercial function is no exception. To stay resilient and keep pace with the evolving…

Items per page